4.7 Article

Propolis supplementation in obese patients with non-alcoholic fatty liver disease: effects on glucose homeostasis, lipid profile, liver function, anthropometric indices and meta-inflammation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

Expression of NF-κB, IL-6, and IL-10 genes, body composition, and hepatic fibrosis in obese patients with NAFLD-Combined effects of oleoylethanolamide supplementation and calorie restriction: A triple-blind randomized controlled clinical trial

Helda Tutunchi et al.

Summary: The study showed that supplementation with OEA combined with weight-loss intervention could significantly reduce inflammation levels and improve body composition in patients with NAFLD.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Chemistry, Medicinal

Protective effects of propolis on hepatic steatosis and fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) evaluated by real-time two-dimensional shear wave elastography: A randomized clinical trial

Davood Soleimani et al.

Summary: Propolis shows potential as a protective agent against hepatic steatosis and fibrosis, as well as reducing serum levels of hs-CRP in patients with NAFLD.

PHYTOTHERAPY RESEARCH (2021)

Review Endocrinology & Metabolism

Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies

Norbert Stefan et al.

LANCET DIABETES & ENDOCRINOLOGY (2019)

Review Chemistry, Medicinal

The use of Brazilian propolis for discovery and development of novel anti-inflammatory drugs

Marcelo Franchin et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Nutrition & Dietetics

Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids

Marcelo Macedo Rogero et al.

NUTRIENTS (2018)

Article Integrative & Complementary Medicine

The Role of Propolis in Oxidative Stress and Lipid Metabolism: A Randomized Controlled Trial

Veronica Mujica et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)

Article Medicine, Research & Experimental

Does propolis have any effect on non-alcoholic fatty liver disease?

Kemal Kismet et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Review Gastroenterology & Hepatology

Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives

Federico Salomone et al.

LIVER INTERNATIONAL (2016)

Article Environmental Sciences

Brazilian Green Propolis Improves Antioxidant Function in Patients with Type 2 Diabetes Mellitus

Liting Zhao et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2016)

Review Biochemistry & Molecular Biology

A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence

Jonathan L. Temple et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Review Integrative & Complementary Medicine

Propolis: A Complex Natural Product with a Plethora of Biological Activities That Can Be Explored for Drug Development

Ricardo Silva-Carvalho et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)

Review Biochemistry & Molecular Biology

What We Talk About When We Talk About Fat

Evan D. Rosen et al.

Article Chemistry, Applied

Propolis chemical composition and honeybee resistance against Varroa destructor

M. Popova et al.

NATURAL PRODUCT RESEARCH (2014)

Article Gastroenterology & Hepatology

Role of diet and nutritional management in non-alcoholic fatty liver disease

Jian-Gao Fan et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)

Review Oncology

Mechanisms of insulin resistance in obesity

Jianping Ye

FRONTIERS OF MEDICINE (2013)

Article Endocrinology & Metabolism

Caffeic acid phenethyl ester reduces the activation of the nuclear factor κB pathway by high-fat diet-induced obesity in mice

Rosangela Maria Neves Bezerra et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2012)

Review Biochemistry & Molecular Biology

Propolis research and the chemistry of plant products

Antonio Salatino et al.

NATURAL PRODUCT REPORTS (2011)

Article Endocrinology & Metabolism

Glycemic control and anti-osteopathic effect of propolis in diabetic rats

M. Al-Hariri et al.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2011)

Review Gastroenterology & Hepatology

Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications

Elisa Fabbrini et al.

HEPATOLOGY (2010)

Article Medicine, General & Internal

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.

Arun J. Sanyal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Pharmacology & Pharmacy

Propolis Prevents Diet-Induced Hyperlipidemia and Mitigates Weight Gain in Diet-Induced Obesity in Mice

Satomi Koya-Miyata et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)

Article Medicine, Research & Experimental

Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes

Allison B. Goldfine et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2008)

Article Endocrinology & Metabolism

Intracellular Lipid Accumulation in Liver and Muscle and the Insulin Resistance Syndrome

Cristina Lara-Castro et al.

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2008)

Article Gastroenterology & Hepatology

The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation

Masahide Hamaguchi et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)

Article Plant Sciences

Chemical diversity of propolis and the problem of standardization

V Bankova

JOURNAL OF ETHNOPHARMACOLOGY (2005)

Article Pharmacology & Pharmacy

Effects of propolis on blood glucose, blood lipid and free radicals in rats with diabetes mellitus

HU Fuliang et al.

PHARMACOLOGICAL RESEARCH (2005)